Paper II — 2025 March (Supplementary) (2010 Scheme) — Q6
2 min read
Paper II
2025 March (Supplementary) (2010 Scheme)
Question
Chelating agents
Q63 marksShort Notes
Answer
Chelating agents bind metal ions to form stable, water-soluble complexes that are readily excreted, used as antidotes in heavy metal poisoning.
By metal:
Lead: EDTA (edetate calcium disodium), Dimercaprol (severe cases), Succimer (DMSA — oral, an important advance over dimercaprol for outpatient/paediatric use, avoiding painful IM injection).
MOA: form stable ring-shaped complexes with the metal ion (chelation), converting a toxic, tissue-bound form into an inert, water-soluble form excreted mainly by the kidney.
Adverse effects: hypotension and pain at injection site (dimercaprol), hypocalcemia (EDTA, if not given as the calcium-disodium salt), nephrotoxicity, and depletion of essential trace metals with prolonged use.